MEDPACE HOLDINGS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of Directors: Fred B. Davenport, Jr.

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Fred B. Davenport, Jr.”): 16,532,146 for, 10,556,096 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 127 asset managers below reported 6,232,430 for, 3,123 against, 3,693,310 withheld, 369,191 abstained.

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

Description as filed by funds: Election of Directors: Cornelius P. McCarthy III

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Cornelius P. McCarthy III”): 18,826,983 for, 8,261,259 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 126 asset managers below reported 7,776,157 for, 3,123 against, 2,161,413 withheld, 355,561 abstained.

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually.

MEDPACE HOLDINGS INC.’s own tally for this item (“4. Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of S”): 27,081,976 for, 4,407 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to amend the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually was approved based upon the followin…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 133 asset managers below reported 10,026,401 for, 1,511 against.

Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.

MEDPACE HOLDINGS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers”): 26,373,187 for, 701,630 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (23 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Section 14a Executive Compensation” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “To approve, on an advisory basis, the H of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.” (2 managers, 15,420 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 131 managers: 10,005,180 for, 1,247 against, 5,608 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 395 managers: 24,358,764 for, 950,034 against, 697 not voted, 519 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

MEDPACE HOLDINGS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December ”): 27,926,739 for, 800,797 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 136 asset managers below reported 10,339,039 for, 18,542 against, 5,608 abstained.

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.